← FDA GUIDANCE
FDA GUIDANCE · FINALAugust 14, 2026

CVM GFI #260 - Type VII Veterinary Master File for Research and Development and Risk Reviews

What this record is not

Guidance details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.

Status
Final
Topic
Biotechnology, Cellular & Gene Therapy, Animal Cell-Based Products
Issue date
August 14, 2026
CHECKING ACCESS

Checking your Professional access…

READ THE FULL GUIDANCE

The complete guidance document — every recommendation and its scope — is published by the FDA. SPEQ surfaces and indexes it for reference; the authoritative text lives on fda.gov.

View on fda.gov →

PUT THIS GUIDANCE TO WORK

Decode the standardsThe requirements this guidance interprets →Assess your quality systemBaseline against 12 GxP domains in 10 minutes →All FDA guidanceBrowse the live guidance feed →